comparemela.com

Department Of Angiology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Antithrombotic prophylaxis of no benefit in symptomatic outpatients with COVID-19: Lancet

Delhi: Results from two randomized trials indicate that routine use of antithrombotic therapies to prevent thromboembolic complications is futile among symptomatic outpatients with COVID-19. The.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.